Yabao Pharmaceutical Group Co., Ltd (SHA:600351)
China flag China · Delayed Price · Currency is CNY
7.15
+0.16 (2.29%)
Aug 20, 2026, 3:00 PM CST

SHA:600351 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
921.17820.51578.59617.64668.5477.05
Trading Asset Securities
3.41-----
Cash & Short-Term Investments
924.58820.51578.59617.64668.5477.05
Cash Growth
40.94%41.81%-6.32%-7.61%40.13%36.10%
Accounts Receivable
339.29361.99444.15601.32716.18667.79
Other Receivables
16.1426.7943.9535.1470.5991.72
Receivables
355.43388.78488.1636.45786.77759.52
Inventory
273.59315.73413.05442.13449.14521.01
Prepaid Expenses
-0.110.0100.03-
Other Current Assets
48.5252.9479.5656.8149.939.51
Total Current Assets
1,6021,5781,5591,7531,9541,797
Property, Plant & Equipment
1,0111,0541,2031,3081,3771,454
Long-Term Investments
298.88317.47372.61377.72346.43314.68
Goodwill
26.2726.2726.2726.2726.2774.57
Other Intangible Assets
144.72136.57146.99154.96155.6157.39
Long-Term Deferred Tax Assets
28.8423.8741.8931.234.6128.46
Long-Term Deferred Charges
82.9889.05138.28155.8179.27146.35
Other Long-Term Assets
57.4760.755.4646.6957.73104.03
Total Assets
3,2523,2863,5443,8544,1314,077

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
123.99106.39153.34191.7166.94120.66
Accrued Expenses
120.69111.396.17123.09130.69111.71
Short-Term Debt
--90.07200.22410.26502.37
Current Portion of Long-Term Debt
0.020.02-221.011.01
Current Portion of Leases
1.620.563.573.413.283.85
Current Income Taxes Payable
20.3511.494.076.3212.245.99
Current Unearned Revenue
42.7668.7780.4467.32108.4890.2
Other Current Liabilities
111.2886.71154.35191.4187.77169.62
Total Current Liabilities
420.71385.24582.02785.461,0411,005
Long-Term Debt
3535--223
Long-Term Leases
1.60.572.063.375.18.52
Long-Term Unearned Revenue
28.5337.1337.2443.5347.9946.1
Long-Term Deferred Tax Liabilities
3.13.1799.269.9511.36
Other Long-Term Liabilities
--18.7218.7218.7218.72
Total Liabilities
488.93461.11649.02860.331,1241,113

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
692692720770770770
Additional Paid-In Capital
550.45550.45703.76955.1955.32955.32
Retained Earnings
1,6061,6711,5611,4261,2651,222
Treasury Stock
---66.06-150.45--
Comprehensive Income & Other
-27.5-28.86-25.7-24.41-20.01-20.05
Total Common Equity
2,8212,8842,8932,9762,9702,927
Minority Interest
-57.47-59.112.2817.1236.5636.62
Shareholders' Equity
2,7642,8252,8952,9933,0072,964
Total Liabilities & Equity
3,2523,2863,5443,8544,1314,077

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
38.2436.1595.7209441.65538.74
Net Cash (Debt)
886.34784.36482.9408.64226.85-61.69
Net Cash Growth
72.56%62.43%18.17%80.14%--
Net Cash Per Share
1.281.120.670.540.29-0.08
Filing Date Shares Outstanding
692692700720770770
Total Common Shares Outstanding
692692709.5748.7770770
Working Capital
1,1811,193977.3967.58913.67791.68
Book Value Per Share
4.084.174.083.983.863.80
Tangible Book Value
2,6502,7212,7192,7952,7882,695
Tangible Book Value Per Share
3.833.933.833.733.623.50
Buildings
1,5361,5371,6311,6131,5971,545
Machinery
1,3291,3691,3861,3601,3421,340
Construction In Progress
7.723.9315.4957.4125.8326.48